 |
|
|
| |
Ledipasvir/Sofosbuvir for the Treatment of Patients With
Chronic Genotype 4 or 5 HCV Infection
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Armand Abergel1, Veronique Loustaud-Ratti2, Sophie Metivier3, Deyuan Jiang4, Kathryn Kersey4, Steven J. Knox4, Evguenia Svarovskaia4, Philip S. Pang4, Didier Samuel5, Tarik Asselah6
1Centre Hospitalier Universitaire-Estaing, Universite d'Auvergne,
Clermont-Ferrand, France; 2Centre Hospitalier Universitaire-Limoges, Inserm UMR 1092, Limoges, France; 3Centre Hospitalier Universitaire-Purpan, Toulouse, France; 4Gilead Sciences, Inc., Foster City, California, USA; 5Hôpital Paul Brousse, Universite Paris Sud, Villejuif, France; 6University Paris Diderot and INSERM U773, Beaujon Hospital, Clichy, France
|
| |
|
|
|
|
|
